The laser atherectomy devices market size has grown strongly in recent years. It will grow from $1.3 billion in 2025 to $1.41 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising prevalence of peripheral artery disease, increasing incidence of cardiovascular disorders, expansion of catheter-based interventions, availability of advanced laser technologies, growth of interventional cardiology centers.
The laser atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular treatments, rising adoption of image-guided interventions, expansion of outpatient cardiovascular procedures, technological advancements in laser systems, growing focus on reducing restenosis rates. Major trends in the forecast period include increasing adoption of laser-based plaque removal techniques, rising use of computer-controlled atherectomy systems, growing demand for minimally invasive vascular interventions, expansion of peripheral and neurovascular applications, enhanced focus on precision and procedural safety.
The laser atherectomy devices market is also anticipated to witness growth due to the rising incidence of cardiovascular diseases (CVD). CVD encompasses diseases affecting the heart or blood vessels, impacting the circulatory system. The surge in cardiovascular diseases leads to an increased number of patients requiring treatment for arterial occlusions and atherosclerotic plaque, thereby creating a higher demand for laser atherectomy devices. For example, in October 2024, data released by the Centers for Disease Control and Prevention, a United States-based government agency, indicated that in 2023 cardiovascular diseases were responsible for 919,032 deaths, representing approximately one out of every three deaths nationwide. Coronary heart disease remained the most common form of heart disease, and notably, nearly one in six cardiovascular-related deaths occurred among adults under the age of 65. Therefore, the growth of cardiovascular diseases propels the laser atherectomy devices market.
Prominent companies in the laser atherectomy devices market are also investing efforts in developing advanced solutions, such as atherectomy platforms, to meet the demands of larger customer bases, drive more sales, and enhance revenue. An atherectomy platform constitutes a comprehensive system or set of tools designed for treating atherosclerosis - a medical condition characterized by plaque buildup in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced FDA clearance for the FreedomFlow, an orbital atherectomy peripheral platform. The distinctive feature of the FreedomFlow platform lies in its contemporary mechanism of action tailored to clear plaque blockages in leg arteries. Its exclusive catheter-based design leverages angular momentum physics, creating a spiral geometry that ensures simultaneous contact with the vessel wall during both advancement and retraction through the incorporation of five diamond-coated spheres. Additionally, a diamond-coated tip facilitates the smooth passage of the driveshaft through narrow blockages. This innovative approach provides physicians with an exceptionally efficient, effective, and adaptable means of treating complex Peripheral Artery Disease (PAD) across a broad spectrum of vessel diameters, ranging from 2 mm in the ankle to 8 mm in the hip. The platform offers greater versatility in addressing multiple arteries and multiple blockages within the same vessel, all achieved with a single device.
In April 2023, Abbott Laboratories, a US-based medical device company, completed the acquisition of Cardiovascular Systems, Inc. for an undisclosed amount. This strategic move enhances Abbott's capabilities to address vascular disease by incorporating CSI's leading atherectomy system designed to prepare vessels for angioplasty or stenting, ultimately restoring blood flow. The acquisition aligns with Abbott's broader investment strategy in its vascular portfolio, fortifying its ability to deliver comprehensive care for patients dealing with peripheral and coronary artery disease. Cardiovascular Systems Inc., a US-based manufacturer of atherectomy devices, now operates as part of Abbott's portfolio.
Major companies operating in the laser atherectomy devices market are Boston Scientific Corporation, Abbott Laboratories, Avinger Inc., AngioDynamics Inc., Cardiovascular Systems Inc., Eximo Medical Ltd., Straub Medical AG, Shockwave Medical Inc., Terumo Corporation, Cordis Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Acotec Scientific Holdings Ltd., Rex Medical LP, ArioMedica Ltd., Advanced Catheter Therapies Inc., B. Braun SE, Olympus Corporation, Koninklijke Philips N.V., Medtronic plc.
North America was the largest region in the laser atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the laser atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the laser atherectomy devices market by increasing costs of imported laser generators, optical fibers, control software, electronic components, and precision manufacturing equipment. Cardiovascular hospitals and surgical centers in North America and Europe are most affected due to reliance on advanced imported laser systems, while Asia-Pacific faces higher export and production costs. These tariffs are raising device acquisition costs and slowing adoption in smaller care settings. However, they are also encouraging domestic innovation, localized assembly of laser systems, and development of cost-optimized atherectomy technologies.
The laser atherectomy devices market research report is one of a series of new reports that provides laser atherectomy devices market statistics, including laser atherectomy devices industry global market size, regional shares, competitors with a laser atherectomy devices market share, detailed laser atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the laser atherectomy devices industry. This laser atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A laser atherectomy device is a medical instrument designed to employ laser energy for breaking down and removing blockages from blood vessels. This device is commonly utilized in the treatment of conditions such as peripheral artery disease (PAD) or atherosclerosis, where plaque buildup in the arteries leads to narrowing or blockages. The laser atherectomy device operates by delivering a high-energy laser beam to the plaque, causing it to vaporize and facilitating the removal of the blockage.
The primary types of laser atherectomy devices include those with computer control and others. Computer control involves the utilization of computer technology to manage and control various systems and processes. These devices find applications in cardiovascular, peripheral vascular, and neurovascular procedures and are employed by hospitals and surgical centers, ambulatory care centers, and other medical facilities.
The laser atherectomy devices market consists of sales of turbo elite, diamondback 360, phoenix atherectomy system, jetstream atherectomy system, hawkone system, and ocelot system. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The laser atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular treatments, rising adoption of image-guided interventions, expansion of outpatient cardiovascular procedures, technological advancements in laser systems, growing focus on reducing restenosis rates. Major trends in the forecast period include increasing adoption of laser-based plaque removal techniques, rising use of computer-controlled atherectomy systems, growing demand for minimally invasive vascular interventions, expansion of peripheral and neurovascular applications, enhanced focus on precision and procedural safety.
The laser atherectomy devices market is also anticipated to witness growth due to the rising incidence of cardiovascular diseases (CVD). CVD encompasses diseases affecting the heart or blood vessels, impacting the circulatory system. The surge in cardiovascular diseases leads to an increased number of patients requiring treatment for arterial occlusions and atherosclerotic plaque, thereby creating a higher demand for laser atherectomy devices. For example, in October 2024, data released by the Centers for Disease Control and Prevention, a United States-based government agency, indicated that in 2023 cardiovascular diseases were responsible for 919,032 deaths, representing approximately one out of every three deaths nationwide. Coronary heart disease remained the most common form of heart disease, and notably, nearly one in six cardiovascular-related deaths occurred among adults under the age of 65. Therefore, the growth of cardiovascular diseases propels the laser atherectomy devices market.
Prominent companies in the laser atherectomy devices market are also investing efforts in developing advanced solutions, such as atherectomy platforms, to meet the demands of larger customer bases, drive more sales, and enhance revenue. An atherectomy platform constitutes a comprehensive system or set of tools designed for treating atherosclerosis - a medical condition characterized by plaque buildup in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced FDA clearance for the FreedomFlow, an orbital atherectomy peripheral platform. The distinctive feature of the FreedomFlow platform lies in its contemporary mechanism of action tailored to clear plaque blockages in leg arteries. Its exclusive catheter-based design leverages angular momentum physics, creating a spiral geometry that ensures simultaneous contact with the vessel wall during both advancement and retraction through the incorporation of five diamond-coated spheres. Additionally, a diamond-coated tip facilitates the smooth passage of the driveshaft through narrow blockages. This innovative approach provides physicians with an exceptionally efficient, effective, and adaptable means of treating complex Peripheral Artery Disease (PAD) across a broad spectrum of vessel diameters, ranging from 2 mm in the ankle to 8 mm in the hip. The platform offers greater versatility in addressing multiple arteries and multiple blockages within the same vessel, all achieved with a single device.
In April 2023, Abbott Laboratories, a US-based medical device company, completed the acquisition of Cardiovascular Systems, Inc. for an undisclosed amount. This strategic move enhances Abbott's capabilities to address vascular disease by incorporating CSI's leading atherectomy system designed to prepare vessels for angioplasty or stenting, ultimately restoring blood flow. The acquisition aligns with Abbott's broader investment strategy in its vascular portfolio, fortifying its ability to deliver comprehensive care for patients dealing with peripheral and coronary artery disease. Cardiovascular Systems Inc., a US-based manufacturer of atherectomy devices, now operates as part of Abbott's portfolio.
Major companies operating in the laser atherectomy devices market are Boston Scientific Corporation, Abbott Laboratories, Avinger Inc., AngioDynamics Inc., Cardiovascular Systems Inc., Eximo Medical Ltd., Straub Medical AG, Shockwave Medical Inc., Terumo Corporation, Cordis Corporation, Cook Medical LLC, Biotronik SE & Co. KG, Acotec Scientific Holdings Ltd., Rex Medical LP, ArioMedica Ltd., Advanced Catheter Therapies Inc., B. Braun SE, Olympus Corporation, Koninklijke Philips N.V., Medtronic plc.
North America was the largest region in the laser atherectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the laser atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the laser atherectomy devices market by increasing costs of imported laser generators, optical fibers, control software, electronic components, and precision manufacturing equipment. Cardiovascular hospitals and surgical centers in North America and Europe are most affected due to reliance on advanced imported laser systems, while Asia-Pacific faces higher export and production costs. These tariffs are raising device acquisition costs and slowing adoption in smaller care settings. However, they are also encouraging domestic innovation, localized assembly of laser systems, and development of cost-optimized atherectomy technologies.
The laser atherectomy devices market research report is one of a series of new reports that provides laser atherectomy devices market statistics, including laser atherectomy devices industry global market size, regional shares, competitors with a laser atherectomy devices market share, detailed laser atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the laser atherectomy devices industry. This laser atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A laser atherectomy device is a medical instrument designed to employ laser energy for breaking down and removing blockages from blood vessels. This device is commonly utilized in the treatment of conditions such as peripheral artery disease (PAD) or atherosclerosis, where plaque buildup in the arteries leads to narrowing or blockages. The laser atherectomy device operates by delivering a high-energy laser beam to the plaque, causing it to vaporize and facilitating the removal of the blockage.
The primary types of laser atherectomy devices include those with computer control and others. Computer control involves the utilization of computer technology to manage and control various systems and processes. These devices find applications in cardiovascular, peripheral vascular, and neurovascular procedures and are employed by hospitals and surgical centers, ambulatory care centers, and other medical facilities.
The laser atherectomy devices market consists of sales of turbo elite, diamondback 360, phoenix atherectomy system, jetstream atherectomy system, hawkone system, and ocelot system. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Laser Atherectomy Devices Market Characteristics
3. Laser Atherectomy Devices Market Supply Chain Analysis
4. Global Laser Atherectomy Devices Market Trends and Strategies
5. Laser Atherectomy Devices Market Analysis of End Use Industries
7. Global Laser Atherectomy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Laser Atherectomy Devices Total Addressable Market (TAM) Analysis for the Market
9. Laser Atherectomy Devices Market Segmentation
10. Laser Atherectomy Devices Market Regional and Country Analysis
11. Asia-Pacific Laser Atherectomy Devices Market
12. China Laser Atherectomy Devices Market
13. India Laser Atherectomy Devices Market
14. Japan Laser Atherectomy Devices Market
15. Australia Laser Atherectomy Devices Market
16. Indonesia Laser Atherectomy Devices Market
17. South Korea Laser Atherectomy Devices Market
18. Taiwan Laser Atherectomy Devices Market
19. South East Asia Laser Atherectomy Devices Market
20. Western Europe Laser Atherectomy Devices Market
21. UK Laser Atherectomy Devices Market
22. Germany Laser Atherectomy Devices Market
23. France Laser Atherectomy Devices Market
24. Italy Laser Atherectomy Devices Market
25. Spain Laser Atherectomy Devices Market
26. Eastern Europe Laser Atherectomy Devices Market
27. Russia Laser Atherectomy Devices Market
28. North America Laser Atherectomy Devices Market
29. USA Laser Atherectomy Devices Market
30. Canada Laser Atherectomy Devices Market
31. South America Laser Atherectomy Devices Market
32. Brazil Laser Atherectomy Devices Market
33. Middle East Laser Atherectomy Devices Market
34. Africa Laser Atherectomy Devices Market
36. Laser Atherectomy Devices Market Competitive Landscape and Company Profiles
37. Laser Atherectomy Devices Market Other Major and Innovative Companies
40. Laser Atherectomy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Laser Atherectomy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses laser atherectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for laser atherectomy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The laser atherectomy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Excimer Laser Atherectomy Devices; Solid-State Laser Atherectomy Devices; Ultraviolet (UV) Laser Atherectomy Devices; Infrared (IR) Laser Atherectomy Devices2) By Application: Cardiovascular; Peripheral Vascular; Neurovascular
3) By End-User: Hospitals And Surgical Centers; Ambulatory Care Centers; Other End-Users
Subsegments:
1) By Excimer Laser Atherectomy Devices: Coronary Excimer Laser Systems; Peripheral Excimer Laser Systems; In-Stent Restenosis (ISR) Laser Systems2) By Solid-State Laser Atherectomy Devices: Nd:YAG Laser Atherectomy Systems; Holmium:YAG Laser Atherectomy Systems; Diode-Based Laser Atherectomy Systems
3) By Ultraviolet (UV) Laser Atherectomy Devices: Pulsed UV Laser Atherectomy Systems; Continuous-Wave UV Laser Atherectomy Systems
4) By Infrared (IR) Laser Atherectomy Devices: Near-Infrared Laser Atherectomy Systems; Mid-Infrared Laser Atherectomy Systems
Companies Mentioned: Boston Scientific Corporation; Abbott Laboratories; Avinger Inc.; AngioDynamics Inc.; Cardiovascular Systems Inc.; Eximo Medical Ltd.; Straub Medical AG; Shockwave Medical Inc.; Terumo Corporation; Cordis Corporation; Cook Medical LLC; Biotronik SE & Co. KG; Acotec Scientific Holdings Ltd.; Rex Medical LP; ArioMedica Ltd.; Advanced Catheter Therapies Inc.; B. Braun SE; Olympus Corporation; Koninklijke Philips N.V.; Medtronic plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Laser Atherectomy Devices market report include:- Boston Scientific Corporation
- Abbott Laboratories
- Avinger Inc.
- AngioDynamics Inc.
- Cardiovascular Systems Inc.
- Eximo Medical Ltd.
- Straub Medical AG
- Shockwave Medical Inc.
- Terumo Corporation
- Cordis Corporation
- Cook Medical LLC
- Biotronik SE & Co. KG
- Acotec Scientific Holdings Ltd.
- Rex Medical LP
- ArioMedica Ltd.
- Advanced Catheter Therapies Inc.
- B. Braun SE
- Olympus Corporation
- Koninklijke Philips N.V.
- Medtronic plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.41 Billion |
| Forecasted Market Value ( USD | $ 1.98 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
